Search Results

NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.

• Authors : Arron, Joseph R.; Winslow, Monte M.; Polleri, Alberto

• Source: Nature. June, 2006, Vol. 441 Issue 7093, p595, 6 p.

Record details

Unveiling some FDA-approved drugs as inhibitors of the store-operated Ca 2+ entry pathway.

• Authors : Rahman S; Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, UK.; Rahman T

Subjects: Calcium Signaling*/Calcium Signaling*/Calcium Signaling*/drug effects ; Drug Approval* ; United States Food and Drug Administration*

• Source: Scientific reports [Sci Rep] 2017 Oct 16; Vol. 7 (1), pp. 12881. Date of Electronic Publication: 2017 Oct 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

[Tacrolimus for therapy of rheumatoid arthritis].

• Authors : Harigai M; Clinical Research Center, Department of Medicine and Rheumatology, Tokyo Medical and Dental University.

Subjects: Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy ; Tacrolimus/Tacrolimus/Tacrolimus/*therapeutic use

• Source: Nihon rinsho. Japanese journal of clinical medicine [Nihon Rinsho] 2005 Jan; Vol. 63 Suppl 1, pp. 508-12.Publisher: Nippon Rinsho Co Country of Publication: Japan NLM ID: 0420546 Publication Model: Print Cited Medium: Print ISSN: 0047-1852 (Print)

Record details